FRANK P. PALANTONI - Corporate Board Profile

LEXICON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2008-03-14	Frank P. Palantoni has been a director since November 2004. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Kathleen M. Wiltsey. ... The current members of the compensation committee are Frank P. Palantoni (chair), Philippe J. Amouyal and Alan S. Nies, M.D. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Frank P. Palantoni $41,483 Fees Earned or Paid in Cash, $64,446 Option Awards, Total $105,929.
2009-03-13	The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Alan S. Nies, M.D. The board of directors, in its business judgment, has determined that Mr. Palantoni, Mr. Amouyal and Dr. Nies are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc.
2010-03-19	The following table presents summary information for the year ended December 31, 2009 regarding the compensation of the non-employee members of our board of directors. Samuel L. Barker, Ph.D. $48,500 $14,946 — $63,446 Philippe J. Amouyal $30,500 $7,473 — $37,973 Raymond Debbane $32,000 $7,473 — $39,473 Robert J. Lefkowitz, M.D. $28,500 $7,473 $50,000 (4) $85,973 Alan S. Nies, M.D. $30,000 $7,473 $75,000 (5) $112,473 Frank P. Palantoni $37,000 $7,473 — $44,473 Christopher J. Sobecki $27,000 $7,473 — $34,473 Judith L. Swain, M.D. $29,500 $7,473 — $36,973 Kathleen M. Wiltsey $28,000 $7,473 — $35,473
2012-03-16	Frank P. Palantoni has been a director since November 2004. Mr. Palantoni provides us with the benefit of his extensive business operations experience, as well as his expertise in compensation and performance management and his broad business and management skills developed while serving in his various leadership positions in the consumer health products industry.
2013-03-25	Frank P. Palantoni has been a director since November 2004. ... The following table presents summary information for the year ended December 31, 2012 regarding the compensation of the non-employee members of our board of directors. ... Frank P. Palantoni $36,000 Fees Earned or Paid in Cash, $25,922 Option Awards, $19,999 Restricted Stock Awards, Total $81,921.
2014-03-14	The following table presents summary information for the year ended December 31, 2013 regarding the compensation of the non-employee members of our board of directors. Name: Frank P. Palantoni Fees Earned or Paid in Cash: $35,500 Option Awards: $30,074 Restricted Stock Awards: $20,000 All Other Compensation: $0 Total: $85,574
2015-03-13	Frank P. Palantoni has been a director since November 2004. He is president of Palantoni & Partners LLC. Compensation Committee chair. Audit Committee member. Director compensation table shows $81,965 total compensation in 2014.
2016-03-18	Frank P. Palantoni has been a director since November 2004 ... The current members of our audit committee are ... Frank P. Palantoni ... The current members of our compensation committee are ... Frank P. Palantoni ... Director Compensation in 2015 ... Frank P. Palantoni $72,363
2017-03-17	The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D. The board of directors, in its business judgment, has determined that Mr. Palantoni, Mr. Amouyal and Dr. Barker are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... Director Compensation in 2016 ... Frank P. Palantoni ... $85,707 ...
2018-03-16	Frank P. Palantoni has been a director since November 2004. Mr. Palantoni provides us with the benefit of his extensive business operations experience. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D. The board of directors, in its business judgment, has determined that Mr. Palantoni is “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. The following table presents summary information for the year ended December 31, 2017 regarding the compensation of the non-employee members of our board of directors. Frank P. Palantoni received total compensation of $85,424 in 2017.
2019-03-15	Frank P. Palantoni has been a director since November 2004. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. ... The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D. ... The following table presents summary information for the year ended December 31, 2018 regarding the compensation of the non-employee members of our board of directors. ... Frank P. Palantoni $34,500 Fees Earned or Paid in Cash, $14,888 Option Awards, $19,999 Restricted Stock Awards, Total $69,387.
2020-03-13	Frank P. Palantoni has been a director since November 2004. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. ... The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D. ... The following table presents summary information for the year ended December 31, 2019 regarding the compensation of the non-employee members of our board of directors. ... Frank P. Palantoni $61,863 Fees Earned or Paid in Cash, $24,460 Option Awards, $19,652 Restricted Stock Unit Awards, Total $105,975.
2021-03-19	Frank P. Palantoni has been a director since November 2004. The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D.
2022-04-08	Frank P. Palantoni has been a director since November 2004. Mr. Palantoni is chief executive officer of Laboratory M2, a clean technology company involved in animal health, crop protection and retail sectors. Mr. Palantoni was president of Palantoni & Partners LLC, an advisory firm for the consumer and health care industries, from 2013 to 2016. He previously served as president of the pet and animal health division of Central Garden & Pet Company, was a partner at P3 Capital Management LLC, an early stage consumer products equity fund, served as chief operating officer and chief executive officer of Prestige Brands Holding, Inc. and held a variety of senior management positions with Novartis AG, including president and chief executive officer, worldwide of the Gerber Products Company, and chief executive officer for North American operations of the Consumer Health Division. Prior to joining Novartis, he held a series of senior management positions with The Danone Group. Mr. Palantoni served as a director of Mondias Natural Products Inc. from 2017 until June 2020 and holds a B.S. from Tufts University and an M.B.A. from Columbia University. Mr. Palantoni provides us with the benefit of his extensive business operations experience, as well as his expertise in compensation and performance management and his broad business and management skills developed while serving in his various leadership positions in the consumer health products industry. Director Compensation in 2021: $115,621.
2023-03-17	The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Judith L. Swain, M.D. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Dr. Swain are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The current members of our compensation committee are Mr. Palantoni (chair), Philippe J. Amouyal and Samuel L. Barker, Ph.D. The board of directors, in its business judgment, has determined that Mr. Palantoni, Mr. Amouyal and Dr. Barker are “independent" in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc. ... The following table presents summary information for the year ended December 31, 2022 regarding the compensation of the non-employee members of our board of directors. ... Frank P. Palantoni $70,000 Fees Earned or Paid in Cash, $20,387 Option Awards, $16,465 Restricted Stock Unit Awards, Total $106,852.